We are live on ! Find out more
Nicholas Company

Nicholas Company Portfolio holdings

AUM $5.47B Turnover 6.8%
1-Year Est. Return 16.96%
This Fund
S&P 500
This Quarter Est. Return
+4.79%
1 Year Est. Return
+16.96%
3 Year Est. Return
+65.72%
5 Year Est. Return
+94.16%
10 Year Est. Return
+404.17%
AUM
$4.21B
AUM Growth
+$64.6M
Cap. Flow
-$99.3M
Cap. Flow %
-2.36%
Top 10 Hldgs %
30.14%
Holding
265
New
11
Increased
89
Reduced
79
Closed
19
Avg Time Held
0.9 years
Top 10 Avg Time Held
0.8 years
Top 20 Avg Time Held
0.8 years

Top Buys

Rank Stock Value
1
CELG
Celgene Corp
CELG
+$36.1M
2
ADT icon
ADT Corp
ADT
+$34.9M
3
PFE icon
Pfizer
PFE
+$27.7M
4
CB icon
Chubb
CB
+$19.3M
5
JCI icon
Johnson Controls International
JCI
+$15.1M

Top Sells

Rank Stock Value
1
LO
LORILLARD INC COM STK
LO
+$79.3M
2
MCRS
MICROS SYSTEMS INC
MCRS
+$73.6M
3
MSI icon
Motorola Solutions
MSI
+$51M
4
BHC icon
Bausch Health
BHC
+$23.5M
5
DTV
DIRECTV COM STK (DE)
DTV
+$15.9M

Sector Composition

Rank Sector Weight
1 Healthcare 28.03%
2 Consumer Discretionary 15.41%
3 Industrials 15.12%
4 Financials 11.91%
5 Technology 8.75%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow Held Since
VTRS icon
101
Viatris
VTRS
$20.9B
$8.04M 0.19%
+155,925
New +$7.66M
2014 Q2
0 quarters
COO icon
102
Cooper Companies
COO
$10.9B
$8.01M 0.19%
236,400
-150,340
-39% -$4.97M
2013 Q2
4 quarters
RSG icon
103
Republic Services
RSG
$70.3B
$7.91M 0.19%
208,405
– –
2013 Q2
4 quarters
SWK icon
104
Stanley Black & Decker
SWK
$14B
$7.79M 0.19%
88,720
– –
2013 Q2
4 quarters
LEG icon
105
DELISTED
Leggett & Platt
LEG
$7.72M 0.18%
225,300
– –
2013 Q2
4 quarters
FIS icon
106
Fidelity National Information Services
FIS
$18.6B
$7.68M 0.18%
140,399
-5,600
-4% -$301K
2013 Q2
4 quarters
GWR
107
DELISTED
Genesee & Wyoming Inc.
GWR
$7.62M 0.18%
72,565
+2,500
+4% +$246K
2014 Q1
1 quarter
INN icon
108
Summit Hotel Properties
INN
$692M
$7.6M 0.18%
717,090
-37,010
-5% -$359K
2013 Q2
4 quarters
DNKN
109
DELISTED
Dunkin' Brands Group, Inc.
DNKN
$7.57M 0.18%
165,160
+80,100
+94% +$3.68M
2014 Q1
1 quarter
RHT
110
DELISTED
Red Hat Inc
RHT
$7.19M 0.17%
130,130
+5,000
+4% +$254K
2013 Q2
4 quarters
ALTR icon
111
DELISTED
Altera Corp
ALTR
$6.96M 0.17%
200,210
– –
2013 Q2
4 quarters
REGN icon
112
Regeneron Pharmaceuticals
REGN
$82B
$6.93M 0.16%
24,525
– –
2013 Q3
3 quarters
MELI icon
113
Mercado Libre
MELI
$94.1B
$6.89M 0.16%
72,255
-25
-0% -$2.19K
2013 Q2
4 quarters
WPC icon
114
W.P. Carey
WPC
$14.7B
$6.86M 0.16%
108,747
-510
-0.5% -$31.1K
2013 Q2
4 quarters
IHG icon
115
InterContinental Hotels
IHG
$24.3B
$6.86M 0.16%
115,557
-17,492
-13% -$913K
2013 Q2
4 quarters
FBIN icon
116
Fortune Brands Innovations
FBIN
$4.77B
$6.59M 0.16%
+193,220
New +$6.63M
2014 Q2
0 quarters
SRCL icon
117
DELISTED
Stericycle Inc
SRCL
$6.52M 0.15%
55,050
– –
2013 Q2
4 quarters
PAY icon
118
DELISTED
Verifone Systems Inc
PAY
$6.31M 0.15%
171,665
+815
+0.5% +$27.8K
2013 Q3
3 quarters
HOT
119
DELISTED
STARWOOD HOTELS & RESORTS WORLDWIDE, INC.
HOT
$6.27M 0.15%
77,560
– –
2013 Q2
4 quarters
PAYX icon
120
Paychex
PAYX
$39.4B
$6.11M 0.15%
147,115
– –
2013 Q2
4 quarters
MNST icon
121
Monster Beverage
MNST
$88.8B
$6.04M 0.14%
1,020,840
– –
2013 Q2
4 quarters
RPM icon
122
RPM International
RPM
$12.8B
$5.98M 0.14%
129,472
-12,500
-9% -$541K
2013 Q2
4 quarters
KNGT
123
DELISTED
KNIGHT TRANSPORTATION INC
KNGT
$5.66M 0.13%
238,265
-45,060
-16% -$1.07M
2013 Q2
4 quarters
KRFT
124
DELISTED
KRAFT FOODS GROUP INC COM STK (VA)
KRFT
$5.61M 0.13%
93,575
– –
2013 Q2
4 quarters
JAZZ icon
125
Jazz Pharmaceuticals
JAZZ
$13.9B
$5.59M 0.13%
38,035
+2,500
+7% +$347K
2013 Q3
3 quarters
3 4
5
6 7

Similar funds

SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
EFG International
EFG International Zurich $5.46B AUM
Antipodes Partners
Antipodes Partners Royal Exchange, Australia $5.46B AUM 26.64% 1-Year Est. Return
Exor N.V.
Exor N.V. Amsterdam, Netherlands $5.46B AUM 6.21% 1-Year Est. Return
Abrams Capital Management
Abrams Capital Management Boston, Massachusetts $5.48B AUM 3.63% 1-Year Est. Return
Voleon Capital Management
Voleon Capital Management Berkeley, California $5.49B AUM 56.94% 1-Year Est. Return
Glenview Capital Management
Glenview Capital Management New York $5.49B AUM 46.89% 1-Year Est. Return
TD Private Client Wealth
TD Private Client Wealth New York $5.44B AUM 18.56% 1-Year Est. Return

Nicholas Company's Q2 2014 Portfolio in Review

As of Q2 2014, Nicholas Company held 265 positions worth $4.21B, up 1.6% from $4.14B the previous quarter. Its ten largest holdings account for 30% of the portfolio.

Nicholas Company's Q2 2014 filing shows 11 new, 89 increased, 79 reduced and 19 closed positions. Its largest new stake was Celgene Corp: 474,120 shares worth $40.7M. The largest sale was LORILLARD INC COM STK, an estimated $79.3M.

By sector, the portfolio is most concentrated in Healthcare at 28% of assets, up from 26% a quarter earlier, followed by Consumer Discretionary and Industrials.

  • Nicholas Company's largest Q2 2014 buy was Celgene Corp: 474,120 shares worth $40.7M.
  • Nicholas Company added most to Pfizer in Q2 2014, an estimated $27.7M increase.
  • Nicholas Company's biggest Q2 2014 reduction was Bausch Health, cutting an estimated $23.5M.
  • Nicholas Company fully exited LORILLARD INC COM STK in Q2 2014, selling an estimated $79.3M.
  • Nicholas Company's ten largest holdings make up 30% of its $4.21B portfolio in Q2 2014.
  • Nicholas Company opened 11 new positions and closed 19 in Q2 2014.
  • Nicholas Company's portfolio value rose 1.6% quarter-over-quarter to $4.21B.

Based on Nicholas Company's 13F filing for Q2 2014, filed 14 Aug 2014.